Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[5] On May 5, 2010 the Italian Medicines Agency (AIFA - Agenzia Italiana del Farmaco) became the first governmental health organization ever (even before the drug received approval in Europe) to authorize afamelanotide as a medicine for therapeutic treatment of Italian citizens to reduce painful photosensitivity stemming from the orphan disease erythropoietic protoporphyria (EPP)
These legal proceedings are ongoing and do not constitute scientific evidence
From a product development perspective, it represents a different approachone that is not based on delivering high-dose actives but on how materials interact with biological systems
J Clin Invest 1983;71(4):91625
Consistently, DMF significantly induced the expression of antioxidant proteins such as Nqo1 and Gpx4, which are critical for detoxification reaction and GSH utilization (Fig
The clinical data reveals the exact opposite
